Skip to main content
. 2019 Nov-Dec;35(6):1505–1510. doi: 10.12669/pjms.35.6.652

Table II.

Dosage groups and mean dosages of Gabapentinoids for different etiologies of NeP.

Etiology Frequency n (%) Pregabalin Dose mg/d (n) Mean Pregabalin dose (mg/d) Mean (±SD) Gabapentin Dose mg/d (n) Mean Gabapentin dose (mg/d) Mean (±SD)

50-75 >75-150 >150-200 >200-300 0-200 >200-300 >300-600 >600-900
Diabetic Neuropathy 128 (50.7) 81 28 5 1 102.04±46.14 1 7 5 0 363.64±167.87
Radicular Pain 62 (24.60) 17 10 8 2 139.19±70.60 6 4 7 8 578.26±295.15
Intercostal Neuralgia 7 (2.77) 2 2 2 0 154.17±51.03 1 0 0 0 200
CRPS 7 (2.77) 4 1 1 1 128.57±95.12 0 0 0 0 -
Fibromyalgia 6 (2.38) 3 2 0 0 105.00±44.72 1 0 0 0 200
Post stroke neuralgia 2 (0.79) 0 2 0 0 150 0 0 0 0 -
Trigeminal Neuralgia 5 (1.98) 5 0 0 0 85.00±13.69 0 0 0 0 -
Carpal Tunnel Syndrome 5 (1.98) 2 1 1 1 170.00±102.16 0 0 0 0 250±70.71
Guillain Barre Syndrome 3 (1.19) 0 1 0 0 150 1 0 0 1 500±565.69
CKD 9 (3.57) 5 0 1 1 117.86±99.70 1 1 0 0 250±70.71
Post-surgical pain 9 (3.57) 5 1 2 0 115.63±74.33 0 0 0 1 900
Post Chemotherapy 5 (3.57) 1 3 0 0 125.00±50.00 0 1 0 0 300
Others 4 (1.58) 4 0 0 0 81.25±23.94 0 0 0 0 -